Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

Autor:	IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant A. Ezzat
Rok vydání:	2018
Předmět:	0301 basic medicine Oncology medicine.medical_specialty business.industry 030209 endocrinology & metabolism General Medicine Postmenopausal osteoporosis 03 medical and health sciences Antiresorptive Drugs 030104 developmental biology 0302 clinical medicine Internal medicine medicine business
Zdroj:	Case Reports in Clinical Medicine. :324-342
ISSN:	2325-7083 2325-7075
DOI:	10.4236/crcm.2018.75030
Popis:	Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bc2d431f9f71b37302ee0b8d2954a74f https://doi.org/10.4236/crcm.2018.75030 Zobrazit plný text záznamu